Skip to main content
Clinical Trials/CTRI/2024/05/067893
CTRI/2024/05/067893
Not yet recruiting
Phase 2

A COMPARATIVE STUDY OF EFFICACY OF BALA TAILA NASYA AND M-7 (HYPOTHETICAL DRUG) IN THE MANAGEMENT OF ARDHAVABHEDAKA W.S.R. TO MIGRAIN - NI

PGIASR RAU JODHPUR RAJASTHA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
PGIASR RAU JODHPUR RAJASTHA
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
PGIASR RAU JODHPUR RAJASTHA

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients’ between 16 to 60 years of age.
  • 2\.Patients with clinical signs and symptoms of Ardhavbhedaka.
  • 3\.Patients of either sex irrespective of their occupation, religion and socio\-economic status.
  • 4\.Patients fit for Bala ail Nasya and Migro\-7
  • Powder (hypothetical drug).
  • 5\. Patients willing to participate in trial and
  • follow up with a signed consent.

Exclusion Criteria

  • 1\.Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc.
  • 2\.Patients with complicated Migraine like status migrainosus, hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
  • 3\.Pregnant and lactating women.
  • 4\.Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials